Testing effectiveness (Phase 2)Active Not RecruitingNCT05873244What this trial is testingCXD101 in Immunotherapy-related Liver CancerWho this might be right forHCC Stephen Chan Lam 26
Not applicableNot Yet RecruitingNCT06024538What this trial is testingRole of Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays in the Resistance of Non-small Cell Lung Cancer to Anti-PD1/PD-L1 TherapiesWho this might be right forLung NeoplasmCancer Associated FibroblastMyeloid-Derived Suppressive Cells Immunosuppression University Hospital, Bordeaux 25
Not applicableLooking for participantsNCT05636605What this trial is testingAnalysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to ImmunotherapyWho this might be right forLung Cancer The Fourth Affiliated Hospital of Zhejiang University School of Medicine 200
Testing effectiveness (Phase 2)Study completedNCT04751929What this trial is testingAbemaciclib With or Without Atezolizumab for mCRPCWho this might be right forProstate CancerMetastatic Castration-resistant Prostate Cancer Dana-Farber Cancer Institute 19
Early research (Phase 1)Looking for participantsNCT06439836What this trial is testingPembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior ImmunotherapyWho this might be right forMetastatic Urothelial CarcinomaUnresectable Urothelial Carcinoma National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Ended earlyNCT02107378What this trial is testingEfficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian CarcinomaWho this might be right forEpithelial Ovarian Carcinoma SOTIO a.s. 22
Not applicableLooking for participantsNCT06717243What this trial is testingGenomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)Who this might be right forSmall Cell Lung CancerLarge Cell Neuroendocrine (NE) TumorsTreatment Failure+3 more Oncology Center of Biochemical Education And Research 111
Testing effectiveness (Phase 2)Looking for participantsNCT05779423What this trial is testingCryoablation+Ipilimumab+Nivolumab in MelanomaWho this might be right forMetastatic MelanomaSkin Cancer Massachusetts General Hospital 37
Not applicableEnded earlyNCT05891197What this trial is testingA Biomarker Screening Protocol for Participants With Solid TumorsWho this might be right forTriple Negative Breast CancerNon-small Cell Lung CancerNon Small Cell Lung Cancer+19 more Lyell Immunopharma, Inc. 10
Early research (Phase 1)Study completedNCT05544227What this trial is testingPhase 1 Trial of SYNC-T - Immunotherapy for Advanced/Metastatic Castration-Resistant Prostate CancerWho this might be right forMetastatic Castration-resistant Prostate Cancer Williams Cancer Foundation 15
Testing effectiveness (Phase 2)Study completedNCT00901342What this trial is testingOpen Label Study of Sipuleucel-T in Metastatic Prostate CancerWho this might be right forProstate Cancer Dendreon 104
Testing effectiveness (Phase 2)Looking for participantsNCT05944237What this trial is testingHTL0039732 in Participants With Advanced Solid TumoursWho this might be right forNeoplasmsProstatic Neoplasms, Castration-ResistantStomach Neoplasms+11 more Cancer Research UK 150
Early research (Phase 1)Study completedNCT02423928What this trial is testingPhase I Clinical Trial of Cryoimmunotherapy Against Prostate CancerWho this might be right forProstate Cancer Alden Cancer Therapy II 18
Testing effectiveness (Phase 2)Ended earlyNCT02554812What this trial is testingAvelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)Who this might be right forAdvanced Cancer Pfizer 409
Not applicableLooking for participantsNCT07384897What this trial is testingImmune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung DiseaseWho this might be right forLung Cancer (Diagnosis)SarcoidosisChronic Obstructive Pulmonary Disease+2 more Université Catholique de Louvain 425
Early research (Phase 1)Study completedNCT03629756What this trial is testingEvaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced MalignanciesWho this might be right forNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and NeckBreast Cancer+9 more Arcus Biosciences, Inc. 48
Testing effectiveness (Phase 2)Looking for participantsNCT07158489What this trial is testingOvercoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLCWho this might be right forNSCLCNSCLC (Advanced Non-small Cell Lung Cancer) Swiss Cancer Institute 47
Not applicableStudy completedNCT04253080What this trial is testingExpression of IL4 Induced Gene 1 in Patients With Cutaneous Melanoma: Value in Prognosis and/or in Predictive Response to Immune Checkpoint InhibitorsWho this might be right forCutaneous Melanoma Assistance Publique - Hôpitaux de Paris 127
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06634667What this trial is testingThird-generation EGFR-TKI Plus Anlotinib as Maintenance for NSCLC With Small Cell Transformation After EGFR-TKI ResistanceWho this might be right forNon-small Cell Lung Cancer Hunan Province Tumor Hospital 30
Not applicableLooking for participantsNCT07761871What this trial is testingExercise and Nutritional Intervention in Patients With Melanoma Receiving ImmunotherapyWho this might be right forMelanoma Institute of Oncology Ljubljana 40